Physician profile
Michael Makowski
NPI 1932630951
$24,244.04
in general payments reported to CMS, 2019-2025
12 companies · $10K in 2025
The $10K reported for 2025 was more than what 79% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2021: $151 · 2022: $4,382 · 2023: $5,627 · 2024: $2,360 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,191 · Travel and Lodging: $9,094 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,190.63 |
| Travel and Lodging | $9,094.21 |
| Education | $101.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $18,708.88 | 2022-2025 | Pro, T2 Alpha, Gamma |
| Arthrex, INC. | $1,726.69 | 2023 | Distal Extremities Implants Trauma Ankle Fracture |
| Rock Medical Orthopedics, INC. | $1,464.96 | 2019-2023 | |
| Innovation Technologies INC | $566.79 | 2022-2024 | Irrisept |
| Novus Surgical Consultants | $449.01 | 2023 | |
| Si-Bone, INC. | $372.64 | 2021-2023 | |
| Globus Medical, INC. | $324.25 | 2023-2025 | Anthem, Precice® Intramedullary Limb Lengthening System, Autobahn |
| Depuy Synthes Sales INC. | $175.67 | 2024 | Tfn-Advance |
| Biocomposites INC | $157.77 | 2025 | Stimulan |
| Davol INC. | $137.29 | 2022 | |
| Baxter Healthcare | $105.41 | 2025 | Floseal |
| Integra Lifesciences Corporation | $54.68 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Makowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.